Teva takes long-running ‘skinny label’ suit to SCOTUS

14-07-2022

Teva takes long-running ‘skinny label’ suit to SCOTUS

JHVEphoto / Shutterstock.com

Generics giant’s petition cites the cost of medicine and first-principles of innovation.


Teva, GSK, Coreg, carvedilol, Hatch-Waxman, skinny label, Supreme Court, SCOTUS, generics, patent infringement

LSIPR